Feb 5 • 16:10 UTC 🇩🇰 Denmark Politiken

Novo Nordisk calls competitors' copies illegal

Novo Nordisk criticizes Hims and Hers for planning to launch a copy of the weight loss drug Wegovy, claiming it poses significant risks to patient safety and threatens its intellectual property, prompting plans for legal action.

📡 Similar Coverage